All articles tagged: Acute embolism and thrombosis of unspecified vein (I82.90)

The risks for diabetes mellitus (DM) and cardiovascular disease (CVD) are increased in the acute and postacute COVID-19 phases, according to a study published online July 19 in PLOS Medicine.Emma Rezel-Potts, Ph.D., from King's College London, and colleagues conducted a cohort study from 2020 to 2021 analyzing electronic records for

Diagnostic accuracy is high in the emergency department, with about 5.7 percent of patients misdiagnosed, according to a report published Dec. 15 by the Agency for Healthcare Research and Quality.David E. Newman-Toker, M.D., Ph.D., from the Johns Hopkins University Evidence-based Practice Center in Baltimore, and colleagues examined d

Warfarin use after bioprosthetic surgical aortic valve replacement (sAVR) is associated with lower all-cause mortality and a decreased risk for thromboembolism compared with not receiving warfarin, according to a study published in the December issue of the Mayo Clinic Proceedings.Ying Huang, M.D., Ph.D., from the Mayo Clinic in R

Combined clopidogrel-aspirin therapy initiated within 72 hours after stroke onset leads to lower risk for new stroke at 90 days among patients with mild ischemic stroke or high-risk transient ischemic attack (TIA) of presumed atherosclerotic cause, according to a study published in the Dec. 28 issue of the New England Journal of Medicine.</p

For individuals with overweight or obesity and knee or hip osteoarthritis (OA), a slow-to-moderate, but not a fast, rate of weight loss is associated with a reduced risk for all-cause mortality, according to a study published online Dec. 6 in Arthritis &amp; Rheumatology.Jie Wei, Ph.D., from Xiangya Hospital in Changsha, China, and col

Oral contraceptive (OC) use is associated with an increased risk for developing a venous thromboembolism (VTE), particularly among women with a high genetic predisposition, according to a study recently published online in the&nbsp;American Journal of Obstetrics &amp; Gynecology.Valeria Lo Faro, Ph.D., from Uppsala University in Sweden,

Outpatient treatment of COVID-19 with nirmatrelvir-ritonavir (Paxlovid) reduces the risk for combined thromboembolic events, but does not affect the risk for other post-COVID-19 conditions (PCCs), according to a study published online Oct. 31 in the Annals of Internal Medicine.George N. Ioannou, B.M.B.Ch., from the University of Washin